Sarepta Therapeutics(SRPT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SRPT Sarepta Therapeutics

未开盘 09-03 16:00:00 EDT

22.99

-0.22

-0.95%

盘后22.75

-0.24-1.04%

19:30 EDT

最高23.34	最低22.42	成交量276.83万
今开23.15	昨收23.21	日振幅3.96%
总市值24.27亿	流通市值22.77亿	总股本1.06亿
成交额6,336万	换手率2.79%	流通股本9,905万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SRPT","market":"US","secType":"STK","nameCN":"Sarepta Therapeutics","latestPrice":22.99,"timestamp":1788465600000,"preClose":23.21,"halted":0,"volume":2768345,"hourTrading":{"tag":"盘后","latestPrice":22.75,"preClose":22.99,"latestTime":"19:30 EDT","volume":48931,"amount":1123308.954,"timestamp":1788478207151,"change":-0.24,"changeRate":-0.010439,"amplitude":0.023923},"delay":0,"changeRate":-0.009478672985782094,"floatShares":99052564,"shares":105571146,"eps":-1.316144,"marketStatus":"未开盘","change":-0.22,"latestTime":"09-03 16:00:00 EDT","open":23.15,"high":23.34,"low":22.42,"amount":63356421.18366,"amplitude":0.039638,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.316144,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788508800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":865396800000,"exchange":"NASDAQ","adjPreClose":23.21,"preHourTrading":{"tag":"盘前","latestPrice":23.19,"preClose":23.21,"latestTime":"09:29 EDT","volume":11082,"amount":256104.03370200002,"timestamp":1788442199999,"change":-0.02,"changeRate":-0.000862,"amplitude":0.014942},"postHourTrading":{"tag":"盘后","latestPrice":22.75,"preClose":22.99,"latestTime":"19:30 EDT","volume":48931,"amount":1123308.954,"timestamp":1788478207151,"change":-0.24,"changeRate":-0.010439,"amplitude":0.023923},"volumeRatio":0.640189,"impliedVol":0.9141,"impliedVolPercentile":0.5794},"requestUrl":"/m/hq/s/SRPT/wiki","defaultTab":"wiki","newsList":[{"id":"1133135751","title":"木头姐周四大举加仓特斯拉与Snowflake，连续抛售Roku近1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1133135751","media":"老虎资讯综合","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133135751?lang=zh_cn&edition=full","pubTime":"2026-06-19 16:31","pubTimestamp":1781857919,"startTime":"0","endTime":"0","summary":"Snowflake此前公布的2027财年第一季度业绩表现强劲，营收同比增长33%至13.9亿美元，经调整后每股收益39美分，均优于市场预期。继续减持Roku，套现近1亿美元与此同时，Ark继续大幅减仓Roku。事实上，本周以来Ark已连续抛售Roku股票。从本轮调仓来看，Ark继续加码AI基础设施和高成长科技股，重点押注特斯拉与Snowflake等长期增长标的，同时持续降低Roku相关仓位，显示其对AI与自动化主题的配置倾向进一步增强。","market":"us","thumbnail":"https://static.tigerbbs.com/0fb0479ff67cd3a760cdce353bcb60ed","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/0fb0479ff67cd3a760cdce353bcb60ed"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"木头姐周四大举加仓特斯拉与Snowflake，连续抛售Roku近1亿美元","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSLI","TSYY","TWST","TSDD","CRSH","ELIL","SNOY","ARKQ","TSII","ARKG","SRPU","ELIS","ARKW","ARKX","07766","SRPT","LLYZ","TSL","TSLA","TSLR","09366","SNOW","TSLZ","07366","ROKU","TSLO","LLII","LLY","09766","TESL","TSLY","TSLW","LLYX","TSLL","TSLS","TSLT","TSLG","TSLQ","TEST","TSLP","ARKK","TLA","SNOU"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1118932123","title":"财报前瞻｜Sarepta Therapeutics本季度营收预计同比下降30.61%，机构观点偏看多","url":"https://stock-news.laohu8.com/highlight/detail?id=1118932123","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118932123?lang=zh_cn&edition=full","pubTime":"2026-04-29 15:46","pubTimestamp":1777448804,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics将于2026年05月06日发布财报，市场关注本季营收与盈利拐点的同步出现及基因疗法商业化节奏。市场一致预期本季度公司营收为4.74亿美元，同比下降30.61%；调整后每股收益为0.99美元，同比上升204.75%，显示在收入同比承压的前提下，盈利端有望出现显著改善；公司上季度未披露本季度的收入或利润指引。公司当前主营由产品销售贡献3.70亿美元，占比83.45%，在整体营收同比下降32.73%的环境下，核心商业化产品仍是基本盘。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报前瞻｜Sarepta Therapeutics本季度营收预计同比下降30.61%，机构观点偏看多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRPT"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1153818821","title":"ETF日报｜2倍做多Firefly Aerospace ETF涨超36%；2倍做多Arm ETF涨超32%；成长科技与贵金属双强","url":"https://stock-news.laohu8.com/highlight/detail?id=1153818821","media":"ETF追踪","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153818821?lang=zh_cn&edition=full","pubTime":"2026-03-26 10:25","pubTimestamp":1774491900,"startTime":"0","endTime":"0","summary":"美股ETF涨幅Top5$2倍做多SRPT ETF-Tradr$上涨69.23%。Sarepta Therapeutics周三大涨近35%，此前该公司公布了两项治疗罕见肌肉萎缩症的初步数据。该产品两倍做多航空航天公司$Firefly Aerospace$，标的股价上行带动产品大幅走高，杠杆效应放大收益。有报道称埃隆马斯克旗下的SpaceX最快将于本周提交上市申请，周三太空概念股应声飙升，Firefly Aerospace涨超16%，Intuitive Machines涨近15%，Planet Labs涨超11%，Rocket Lab和AST SpaceMobile涨超10%。$2倍做多ARM ETF- Leverage Shares$上涨32.51%。$罗素2000指数三倍做多ETF-Direxion$上涨3.63%。债券ETF涨幅Top 5$Infracap REIT Preferred ETF$上涨1.33%。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMCZ","PFFR","PLU","RKLB","TNA","XPP","DKNG","FLYT","DAMD","UGL","EDC","EMB","CHAU","ARM","IBB","LUNR","DGP","SLV","NUGT","ARMG","LUNL","SPTL","SRPT","ASTS","TAN","SMCI","DKNX","AMD","FLY","SOXL","TLT","AGQ","NLR","ASTN","PL","SRPU","UYM","RKLZ","PCY","YINN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127376048","title":"Sarepta Therapeutics飙升逾25%！肌肉疾病药物早中期试验结果积极","url":"https://stock-news.laohu8.com/highlight/detail?id=1127376048","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127376048?lang=zh_cn&edition=full","pubTime":"2026-03-25 21:51","pubTimestamp":1774446665,"startTime":"0","endTime":"0","summary":"3月25日，$Sarepta Therapeutics(SRPT)$盘初飙升逾25%！该公司肌肉疾病药物早中期试验结果积极。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4539","IE00BFTCPJ56.SGD","SRPT","IE00BJT1NW94.SGD","BK4585","BK4139","IE0002141913.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106360538","title":"Sarepta Therapeutics股价盘前上涨3.2%，肌肉疾病药物早中期试验结果积极","url":"https://stock-news.laohu8.com/highlight/detail?id=1106360538","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106360538?lang=zh_cn&edition=full","pubTime":"2026-03-25 20:30","pubTimestamp":1774441857,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics的股价在盘前交易中上涨了3.2%，这一上涨源于其针对肌肉疾病的药物在早中期临床试验中显示出积极前景。试验数据的乐观信号提振了投资者信心，市场对该药物后续研发进展抱以期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IE0009355771.USD","SRPT","IE00BJJMRZ35.SGD","BK4139","SRPU","IE00BJT1NW94.SGD","IE0002141913.USD","IE00B2B36J28.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161884966","title":"Sarepta Therapeutics：研究中多数不良事件为轻至中度且与剂量无关","url":"https://stock-news.laohu8.com/highlight/detail?id=1161884966","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161884966?lang=zh_cn&edition=full","pubTime":"2026-03-25 20:06","pubTimestamp":1774440394,"startTime":"0","endTime":"0","summary":"在Sarepta Therapeutics进行的研究中，所观察到的不良事件大多呈现轻度至中度表现，且未显示出剂量依赖性特征。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4139","IE0009355771.USD","SRPT","BK4585","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","SRPU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193886488","title":"Sarepta Therapeutics概念验证数据：单剂量SRP-1001与SRP-1003可降低靶蛋白或mRNA水平","url":"https://stock-news.laohu8.com/highlight/detail?id=1193886488","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193886488?lang=zh_cn&edition=full","pubTime":"2026-03-25 20:06","pubTimestamp":1774440383,"startTime":"0","endTime":"0","summary":"最新概念验证研究数据显示，Sarepta Therapeutics研发的SRP-1001和SRP-1003在单次给药后，能有效降低目标蛋白或信使核糖核酸（mRNA）的表达水平。这一突破性进展为相关疗法的后续开发奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00BFTCPJ56.SGD","BK4139","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","SRPT","IE00B2B36J28.USD","IE0002141913.USD","SRPU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100608630","title":"FDA确认Sarepta可提交Essence研究及真实世界证据用于新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1100608630","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100608630?lang=zh_cn&edition=full","pubTime":"2026-03-19 20:32","pubTimestamp":1773923522,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局已正式批准Sarepta Therapeutics公司提交其Essence临床研究数据及真实世界证据，作为支持新药申请的关键材料。这一决定为Sarepta推进相关疗法审批流程扫清了重要障碍。FDA的认可标志着监管机构对创新证据采集方式的开放性态度，也为生物技术行业树立了新的审评标准。公司表示将按计划提交完整数据包，并与FDA保持密切沟通以推进后续流程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","SRPT","SRPU","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4585","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111209231","title":"Sarepta Therapeutics 请求与FDA会面 探讨提交补充新药申请事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1111209231","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111209231?lang=zh_cn&edition=full","pubTime":"2026-03-19 20:31","pubTimestamp":1773923518,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics Inc. 已正式向美国食品药品监督管理局（FDA）提出会面请求，旨在讨论提交补充新药申请（sNDA）的相关事宜。此次会议将聚焦于新药申请材料的准备与提交策略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00BFTCPJ56.SGD","BK4139","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","SRPT","IE00B2B36J28.USD","IE0002141913.USD","SRPU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518462278","title":"Sarepta Therapeutics, Inc.跌2.94% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2518462278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518462278?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:09","pubTimestamp":1741615795,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时09分，Sarepta Therapeutics, Inc.股票出现波动，股价大幅跳水2.94%。Sarepta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3218.06%、697.98%、112.83%，振幅较大的相关个股有Scisparc Ltd.、Pmgc Holdings Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、32.14%、30.70%。Sarepta Therapeutics, Inc.公司简介：Sarepta Therapeutics公司是一家专注于治疗罕见、传染病和其他疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022095596403f8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022095596403f8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","IE0002141913.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","SRPT","BK4139","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517469013","title":"Sarepta Therapeutics(SRPT.US)获Scotiabank首次覆盖，给予与大盘持平评级, 目标价105.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517469013","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517469013?lang=zh_cn&edition=full","pubTime":"2025-03-08 06:13","pubTimestamp":1741385581,"startTime":"0","endTime":"0","summary":"Sarepta Therapeutics(SRPT.US)获Scotiabank首次覆盖，给予与大盘持平评级, 目标价105.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08061348605304.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","SRPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516938650","title":"Sarepta Therapeutics, Inc.盘中异动 下午盘股价大跌5.00%报101.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516938650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516938650?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:27","pubTimestamp":1741030063,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时27分，Sarepta Therapeutics, Inc.股票出现波动，股价大幅下跌5.00%。Sarepta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4540.23%、206.18%、181.06%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Sarepta Therapeutics, Inc.公司简介：Sarepta Therapeutics公司是一家专注于治疗罕见、传染病和其他疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304032743abe68594&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304032743abe68594&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4585","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4139","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","SRPT","IE0002141913.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516554802","title":"Sarepta Therapeutics, Inc.2024财年实现净利润2.35亿美元，同比增加143.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516554802","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516554802?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:01","pubTimestamp":1740931283,"startTime":"0","endTime":"0","summary":"3月3日，Sarepta Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为2.35亿美元，同比增加143.84%；其中营业收入为19.02亿美元，同比增加53.02%，每股基本收益为2.47美元。从资产负债表来看，Sarepta Therapeutics, Inc.总负债24.35亿美元，其中短期债务13.27百万美元，资产负债比为1.63，流动比率为4.20。机构评级：截至2025年3月3日，当前有20家机构对Sarepta Therapeutics, Inc.目标价做出预测，其中目标均价为179.80美元，其中最低目标价为75.00美元，最高目标价为215.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000209abe4acf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000209abe4acf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SRPT","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514376554","title":"Sarepta Therapeutics, Inc.盘中异动 急速拉升5.13%报108.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514376554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514376554?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:27","pubTimestamp":1740756443,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时27分，Sarepta Therapeutics, Inc.股票出现波动，股价快速上涨5.13%。Sarepta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Bioxcel Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Puma Biotechnology Inc涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1443.74%、406.33%、338.55%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Bioxcel Therapeutics, Inc.，振幅分别为46.60%、43.37%、38.73%。Sarepta Therapeutics, Inc.公司简介：Sarepta Therapeutics公司是一家专注于治疗罕见、传染病和其他疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228232723989686a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228232723989686a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJJMRZ35.SGD","BK4585","IE00BJT1NW94.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","SRPT","IE0002141913.USD","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128208358","title":"萨瑞普塔治疗公司2024年第四季度调整后每股收益$1.90，符合预期，销售额$6.58412亿高于预期$6.27582亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1128208358","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128208358?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:10","pubTimestamp":1740604244,"startTime":"0","endTime":"0","summary":"萨瑞普塔治疗公司报告季度收益为每股$1.90，与分析师的共识预期一致。相比去年同期每股收益$0.82，增长了131.71%。公司报告的季度销售额为$6.58412亿，高出分析师预期的$6.27582亿，增幅达4.91%。与去年同期销售额$3.96781亿相比，这一销售额增加了65.94%。以上内容来自Benzinga Earnings专栏，原文如下：$Sarepta Therapeutics$  reported quarterly earnings of $1.90 per share which met the analyst consensus estimate. This is a 131.71 percent increase over earnings of $0.82 per share from the same period last year.  The company reported quarterly sales of $658.412 million which beat the analyst consensus estimate of $627.582 ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"萨瑞普塔治疗公司2024年第四季度调整后每股收益$1.90，符合预期，销售额$6.58412亿高于预期$6.27582亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512516523","title":"Sarepta Therapeutics, Inc.盘中异动 股价大跌5.52%报101.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512516523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512516523?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889108,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分，Sarepta Therapeutics, Inc.股票出现异动，股价大幅下跌5.52%。截至发稿，该股报101.99美元/股，成交量7.9198万股，换手率0.08%，振幅1.69%。Sarepta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Sarepta Therapeutics, Inc.公司简介：Sarepta Therapeutics公司是一家专注于治疗罕见、传染病和其他疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822314996279715&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021822314996279715&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJT1NW94.SGD","IE0002141913.USD","BK4585","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","SRPT","LENZ","BK4139","IE00BJJMRZ35.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509407788","title":"Sarepta Therapeutics, Inc.盘中异动 下午盘快速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509407788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509407788?lang=zh_cn&edition=full","pubTime":"2025-02-07 03:26","pubTimestamp":1738870000,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日03时26分，Sarepta Therapeutics, Inc.股票出现波动，股价快速下跌5.02%。Sarepta Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Lipella Pharmaceuticals Inc.、Geovax Labs Inc C/Wts 29/09/2025、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Ocean Biomedical, Inc.较为活跃，换手率分别为6915.03%、1742.52%、176.11%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为125.58%、69.09%、64.30%。Sarepta Therapeutics, Inc.公司简介：Sarepta Therapeutics公司是一家专注于治疗罕见、传染病和其他疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207032641987cb825&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207032641987cb825&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","LENZ","IE0009355771.USD","SRPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509321352","title":"Sarepta Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509321352","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509321352?lang=zh_cn&edition=full","pubTime":"2025-02-06 02:04","pubTimestamp":1738778657,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日02时04分，Sarepta Therapeutics, Inc.股票出现波动，股价快速拉升5.00%。Sarepta Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.07%。其相关个股中，Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4544.68%、2237.70%、1686.74%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为122.81%、99.51%、59.58%。Sarepta Therapeutics, Inc.公司简介：Sarepta Therapeutics公司是一家专注于治疗罕见、传染病和其他疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206020417987b9e0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206020417987b9e0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","IE0009355771.USD","IE00B2B36J28.USD","LENZ","IE00BJJMRZ35.SGD","SRPT","BK4585","BK4139","IE00BJT1NW94.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507644241","title":"HC Wainwright & Co.：重申Sarepta Therapeutics(SRPT.US)评级，由卖出调整至卖出评级, 目标价由75.00美元调整至75.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507644241","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507644241?lang=zh_cn&edition=full","pubTime":"2025-01-30 19:54","pubTimestamp":1738238063,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Sarepta Therapeutics(SRPT.US)评级，由卖出调整至卖出评级, 目标价由75.00美元调整至75.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/30195447908892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","SRPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504449484","title":"特朗普2.0时代即将开启，投资机会如何掘金？","url":"https://stock-news.laohu8.com/highlight/detail?id=2504449484","media":"招商基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504449484?lang=zh_cn&edition=full","pubTime":"2025-01-20 10:36","pubTimestamp":1737340585,"startTime":"0","endTime":"0","summary":"美国候任总统唐纳德·特朗普将于美东时间1月20日12时正式宣誓就任美国第47任总统。特朗普2.0时代即将开启，有哪些投资机会可以布局？值得一提的是，科技股在特朗普任期内表现尤为突出，成为推动美股上涨的主要力量。在特朗普第一个任期内，美元整体表现相对弱势。4年任期内，美元指数累计下跌了10.53%。而纵观全球市场，在特朗普上一任期内，恒生科技指数涨幅超过147%，表现甚至略微优于纳斯达克指数。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LECO","NVMI","PTC","ROIV","CHDN","MEDP","BK4561","HOLX","AEP","LNW","FSLR","OTEX","BK4581","AGNC","DPZ","EXE","BPMC","REGN","INTC","GTLB","MTSI","SWKS","CPRT","CME","DOX","NWSA","OKTA","MRNA","COST","NQmain","PCTY","NTAP","CEG","SOFI","SBUX","WTFC","LNT","DUOL","LSTR","ROST","TSCO","LPLA","EA","POOL","BPOP","PODD","INCY","QLD","TRMB","DASH","USAW.SI","MPWR","AMD","DOCU","ORLY","TER","TTWO","EXPE","RADX","PEP","CZR","INSM","NTES","META","HST","REG","PFG","APA","MANH","CFLT","EWBC","HQY","MNDY","HBAN","PAYX","LULU","FER","IDXX","AMZN","FSV","EVRG","AZN","LKQ","MKTX","NDAQ","BK4588","SEIC","MDB","FYBR","INTU","PAA","ALAB","BK4585","NBIX","SBAC","PCVX","ITCI","LIN","BRKR","FRPT","CRWD","BSY","MELI","NVIW.SI","SRPT","HON","CDNS","RIVN","ILMN","CBSH","TECH","BMRN","MCHP","CSCO","LU1815336091.USD","FTAI","Z","RYAAY","NTNX","ONC","BK4550","CSGP","ZM","RPRX","CYBR","TXN","ULTA","ROP","CDW","PCAR","AFRM","FOX","ISRG","NXPI","ON","WWD","RVMD","GILD","LSCC","AMGN","QID","CG","SMCI","TQQQ","TSYW.SI","RGLD","ICLR","ARGX",".IXIC","FWONK","CSX","MNQmain","GMAB","TPG","TSLA","SFM","BKR","JKHY","ALNY","LU0757428866.USD","EBAY","TROW","MRVL","TCOM","BIIB","NTRS","SAIA","ENPH","HOOD","CCEP","CHKP","SSNC","TTEK","JBHT","HSIC","JD","LAMR","CSWI","MARA","MKSI","AVGO","PLTR","PNFP","ADBE","GNTX","MTCH","ODFL","PARA","STLD","FOXA","OLED","TW","ESLT","AAL","CHTR","QQQ","NFLX","QCOM","WDC","FTNT","ADSK","WBA","MNST","ROKU","BK4593","WYNN","EQIX","SIRI","ZS","AUR","NDSN","MMYT","RGEN","MIDD","SNPS","TMUS","FCNCA","ANSS","QXO","FFIV","BK4534","KHC","BKNG","QRVO","ALGN","DDOG","AMAT","CHRW","ADI","PDD","CTAS","ENTG","STX","TTD","CTSH","ERIC","MDLZ","NTRA","ERIE","GLPI","CINF","HLNE","LU0053671581.USD","AAPL","LU2065731478.USD","AXON","TSEM","COO","BK4086","AKAM","CWST","CPB","TEAM","KDP","ASML","CHRD","COIN","DKNG","LOGI","AAON","MSFT","NICE","PSQ","GOOGL","DLTR","GEHC","GRAB","HTHT","USJW.SI","GEN","ARM","CASY","NVDA","LI","EXAS","SQQQ","FAST","TLN","DSGX","RKLB","COKE"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.sarepta.com","stockEarnings":[{"period":"1week","weight":0.0648},{"period":"1month","weight":0.4027},{"period":"3month","weight":0.4597},{"period":"6month","weight":0.3758},{"period":"1year","weight":0.2132},{"period":"ytd","weight":0.0683}],"compareEarnings":[{"period":"1week","weight":0.0027},{"period":"1month","weight":0.0024},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1499},{"period":"1year","weight":0.2011},{"period":"ytd","weight":0.1338}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sarepta Therapeutics, Inc.于1980年7月22日在俄勒冈州注册成立。该公司是一家商业化阶段的生物制药公司，专注于发现和开发独特的RNA靶向疗法、基因疗法和其他遗传治疗方式，用于治疗罕见病。它已开发出多种获批的杜氏肌营养不良症治疗药物，并正在推进针对其他神经肌肉和骨骼疾病的候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.052169},{"month":2,"riseRate":0.571429,"avgChangeRate":0.030294},{"month":3,"riseRate":0.5,"avgChangeRate":0.013831},{"month":4,"riseRate":0.285714,"avgChangeRate":0.007228},{"month":5,"riseRate":0.642857,"avgChangeRate":0.112993},{"month":6,"riseRate":0.714286,"avgChangeRate":0.046133},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.016443},{"month":8,"riseRate":0.733333,"avgChangeRate":0.107102},{"month":9,"riseRate":0.6,"avgChangeRate":0.126607},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.068917},{"month":11,"riseRate":0.714286,"avgChangeRate":0.074513},{"month":12,"riseRate":0.571429,"avgChangeRate":0.010915}],"exchange":"NASDAQ","name":"Sarepta Therapeutics","nameEN":"Sarepta Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Sarepta Therapeutics(SRPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Sarepta Therapeutics(SRPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Sarepta Therapeutics,SRPT,Sarepta Therapeutics股票,Sarepta Therapeutics股票老虎,Sarepta Therapeutics股票老虎国际,Sarepta Therapeutics行情,Sarepta Therapeutics股票行情,Sarepta Therapeutics股价,Sarepta Therapeutics股市,Sarepta Therapeutics股票价格,Sarepta Therapeutics股票交易,Sarepta Therapeutics股票购买,Sarepta Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Sarepta Therapeutics(SRPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Sarepta Therapeutics(SRPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}